These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38239092)

  • 1. Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.
    Beppu T; Yamamura K; Imai K; Hayashi H; Miyamoto Y
    J Surg Oncol; 2024 Apr; 129(5):893-900. PubMed ID: 38239092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era - a nationwide survey in Japan.
    Beppu T; Yamamura K; Sakamoto K; Honda G; Kobayashi S; Endo I; Hasegawa K; Kotake K; Itabashi M; Hashiguchi Y; Kotera Y; Yamaguchi T; Natsume S; Tabuchi K; Kobayashi H; Yamaguchi K; Morita S; Kikuchi K; Miyazaki M; Sugihara K; Yamamoto M; Takahashi K;
    J Hepatobiliary Pancreat Sci; 2023 May; 30(5):591-601. PubMed ID: 36285571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.
    Okuno M; Hatano E; Seo S; Taura K; Yasuchika K; Nakajima A; Yazawa T; Furuyama H; Kawamoto H; Yagi S; Nishitai R; Fujikawa T; Arimoto A; Zaima M; Yoshimura T; Terajima H; Kaihara S; Manaka D; Tanaka A; Uemoto S
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):881-8. PubMed ID: 25155418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Beppu T; Sakamoto Y; Hasegawa K; Honda G; Tanaka K; Kotera Y; Nitta H; Yoshidome H; Hatano E; Ueno M; Takamura H; Baba H; Kosuge T; Kokudo N; Takahashi K; Endo I; Wakabayashi G; Miyazaki M; Uemoto S; Ohta T; Kikuchi K; Yamaue H; Yamamoto M; Takada T
    J Hepatobiliary Pancreat Sci; 2012 Jan; 19(1):72-84. PubMed ID: 22020927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant therapy after resection of colorectal cancer liver metastases.
    Power DG; Kemeny NE
    J Clin Oncol; 2010 May; 28(13):2300-9. PubMed ID: 20368552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resectable colorectal liver metastases: optimal sequencing of chemotherapy.
    Chua TC; Morris DL
    J Gastrointest Cancer; 2012 Sep; 43(3):496-8. PubMed ID: 21365476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
    Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
    Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative second-line chemotherapy is beneficial for resectable liver metastases that occur during or early after adjuvant chemotherapy for colorectal cancer.
    Xu D; Zhu HB; Wang YY; Jin KM; Yan XL; Li J; Wang K; Xing BC
    Int J Colorectal Dis; 2022 Apr; 37(4):805-814. PubMed ID: 35188594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?
    Lubezky N; Geva R; Shmueli E; Nakache R; Klausner JM; Figer A; Ben-Haim M
    World J Surg; 2009 May; 33(5):1028-34. PubMed ID: 19234865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases.
    Kokudo N; Hasegawa K; Makuuchi M
    J Clin Oncol; 2007 Apr; 25(10):1299-300; author reply 1300. PubMed ID: 17401028
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
    Portier G; Elias D; Bouche O; Rougier P; Bosset JF; Saric J; Belghiti J; Piedbois P; Guimbaud R; Nordlinger B; Bugat R; Lazorthes F; Bedenne L
    J Clin Oncol; 2006 Nov; 24(31):4976-82. PubMed ID: 17075115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
    Kornprat P; Jarnagin WR; Gonen M; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
    Ann Surg Oncol; 2007 Mar; 14(3):1151-60. PubMed ID: 17195913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases.
    Spelt L; Hermansson L; Tingstedt B; Andersson R
    World J Surg; 2012 Jan; 36(1):157-63. PubMed ID: 22086255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study.
    Okumura S; Goumard C; Gayet B; Fuks D; Scatton O
    Surgery; 2019 Dec; 166(6):959-966. PubMed ID: 31395397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment strategy for patients with multiple liver metastases of colorectal origin in the era of adjuvant chemotherapy].
    Seyama Y; Matsuda M; Nishikawa T; Tani K; Inada K; Nasu K; Wada I; Maeshiro T; Miyamoto S; Umekita N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1659-61. PubMed ID: 24393880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.